You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
sitemap
HOME
Sitemap
Legal notice
Contact us
ABOUT US
Board of Directors
Management team
Collaborations
PRODUCT DEVELOPMENT
Development pipeline
Central nervous system disorders
Inflammation
INVESTORS
Share monitor
Releases
Share information
Financial information
Governance
Presentations
MEDIA
Releases
Press image gallery
Scientific papers
Recent media coverage
Home
|
Site Map
|
Contact us
|
Search
Suomeksi
Print
Sitemap
Legal notice
Contact us
Sitemap
HOME
Sitemap
Legal notice
Contact us
ABOUT US
Board of Directors
Management team
Collaborations
PRODUCT DEVELOPMENT
Development pipeline
Central nervous system disorders
Nalmefene
SYN115
SYN117
SYN120
SYN118
Inflammation
Ronomilast
VAP-1 Antibody
INVESTORS
Share monitor
Releases
Join mailing list
Share information
Major shareholders
Ownership structure
Price history search
Changes in holdings
Changes in numbers of shares and share capital
Option programs
Authorisations
Analyst coverage
Fact Sheet
factSheetNarrow
Financial information
Interim reports 2005 - 2011
Annual reports 2005 - 2010
Key figures
Formulas for the calculation of the key figures
Adoption of IFRS standards
Listing prospectus
Governance
Corporate governance
Public insiders
Shareholders´ meeting
Shareholders´ meeting 2011
Shareholders´ meeting 2010
Shareholders´ meeting 2009
Shareholders´ meeting 2008
Previous shareholders´ meeting
Auditors
Articles of association
Compensation
Risk management
Disclosure policy
Presentations
Quarterly presentations and webcasts
2011
MEDIA
Releases
Press image gallery
Scientific papers
Recent media coverage
false,false,1
© Copyright Biotie Therapies. 2011 |
Legal Notice